Author

J. Mattsson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Martin-Bernabe· 1 shared A. Mezheyeuski· 1 shared A. Mortha· 1 shared A. Portyanko· 1 shared A. S. Carreira· 1 shared B. Glimelius· 1 shared B. Nodin· 1 shared C. Hedner· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Martin-Bernabe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease

K. T. Reid, S. J. Colpitts, J. A. Mathews, A. S. Carreira, J. M. Murphy, D. T. Borovsky, W. Cui, T. A. Moya, N. Sachewsky, J. An, Y. Xia, A. Mortha, J. B. Lee, L. Zhang, I. Novitzky-Basso, , S. Q. Crome

This study demonstrates that IL-10-producing group 2 innate lymphoid cells (ILC210) can suppress Graft-versus-Host Disease (GVHD) in a humanized model without compromising graft-versus-leukemic effects.

bioRxiv · Aug 21, 2023Immunology

The ratio of cytotoxic lymphocytes to M2-like macrophages is prognostic in immunogenic tumors

A. Mezheyeuski, M. Backman, J. Mattsson, A. Martin-Bernabe, C. Larsson, I. Hrynchyk, K. Hammarström, S. Ström, J. Ekström, S. Mauchanski, S. Khelashvili, M. Agnarsdottir, P.-H. Edqvist, J. Huvila, U. Segersten, , T. Sjöblom

The paper identifies a prognostic signature based on the ratio of cytotoxic lymphocytes to M2-like macrophages in tumor microenvironments, showing better survival prediction than existing immune scores in colon cancer and other high-mutation burden cancers.

bioRxiv · Mar 24, 2021 · PreprintCancer Biology